Apollo, Morgan Stanley Gate Funds as Private Credit Exits Hit 17%
Apollo capped Q2 redemptions at its $26B Debt Solutions BDC after 16.8% requested, while Morgan Stanley’s $7B North Haven fund gated at 5% on 11.6% requests.
Apollo capped Q2 redemptions at its $26B Debt Solutions BDC after 16.8% requested, while Morgan Stanley’s $7B North Haven fund gated at 5% on 11.6% requests.
The Nasdaq fell 2.2% Monday and the VIX jumped 13% as semis cracked nearly 8%. Mag 7 fractured: NVDA -4%, Alphabet hit hard, MSFT and AAPL held.
How VC actually works: seed through growth, what’s in a term sheet, how dilution stacks up round by round, and what happens when a down round hits.
The 30-year Treasury yield is at 4.94% as the Fed holds at 3.50-3.75% and nine officials pencil in 2026 rate hikes. What it means for markets.
Argan posted record $291M Q1 revenue and $3.24 EPS as gas-fired power demand for AI data centers surges. AGX now trades above every published analyst target.
What earnings whisper numbers are, what post-earnings announcement drift (PEAD) is, and why a ‘beat’ sometimes sends a stock lower.
Qualcomm is in advanced talks to buy AI software startup Modular for ~$4B, on top of a reported $8-10B run at Tenstorrent. The combined ~$14B is Qualcomm’s biggest AI bet yet.
AbbVie agreed to buy Apogee Therapeutics for $10.9B all-cash at a 49% premium, adding IL-13 candidate zumilokibart to challenge Dupixent. ABBV rose 6%.
How the Treasury cash-futures basis trade actually works: repo-financed long bonds, short futures, the convergence math, and why hedge funds risk $1T+ on it.
Building-materials giant CRH is reportedly close to buying Arcosa for $8B+, what would be its largest acquisition and a major US infrastructure roll-up.